Follow
Sofia Mary Benedict Victor
Sofia Mary Benedict Victor
Research Assistant, New York Blood Center
Verified email at nybc.org
Title
Cited by
Cited by
Year
Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro
F Curreli, SMB Victor, S Ahmed, A Drelich, X Tong, CTK Tseng, CD Hillyer, ...
MBio 11 (6), 10.1128/mbio. 02451-20, 2020
582020
Preclinical optimization of gp120 entry antagonists as anti-HIV-1 agents with improved cytotoxicity and ADME properties through rational design, synthesis, and antiviral evaluation
F Curreli, S Ahmed, SM Benedict Victor, IR Iusupov, DS Belov, PO Markov, ...
Journal of medicinal chemistry 63 (4), 1724-1749, 2020
342020
Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitors
F Curreli, S Ahmed, SMB Victor, IR Iusupov, EA Spiridonov, DS Belov, ...
Bioorganic & medicinal chemistry 32, 116000, 2021
102021
Identification of combinations of protein kinase C activators and histone deacetylase inhibitors that potently reactivate latent HIV
F Curreli, S Ahmed, SMB Victor, AK Debnath
Viruses 12 (6), 609, 2020
82020
Discovery of highly potent fusion inhibitors with potential Pan-coronavirus activity that effectively inhibit major COVID-19 variants of concern (VOCs) in Pseudovirus-based assays
F Curreli, S Ahmed, SMB Victor, A Drelich, SS Panda, A Altieri, AV Kurkin, ...
Viruses 14 (1), 69, 2021
62021
Discovery of highly potent pancoronavirus fusion inhibitors that also effectively inhibit COVID-19 variants from the UK (Alpha), South Africa (Beta), and India (Delta)
F Curreli, S Ahmed, SMB Victor, A Drelich, SS Panda, A Altieri, AV Kurkin, ...
2021
Discovery of highly potent pancoronavirus fusion inhibitors that also effectively inhibit COVID-19 variants from the UK and South Africa
F Curreli, S Ahmed, SMB Victor, A Drelich, SS Panda, A Altieri, AV Kurkin, ...
bioRxiv, 2021.09. 03.458877, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–7